Jane Street’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-155,591
Closed -$245K 12099
2025
Q4
$482K Sell
155,591
-546,474
-78% -$1.56M ﹤0.01% 7766
2025
Q3
$1.85M Buy
+702,065
New +$1.55M ﹤0.01% 5087
2025
Q2
Sell
-683,423
Closed -$745K 10097
2025
Q1
$752K Buy
683,423
+670,649
+5,250% +$775K ﹤0.01% 6100
2024
Q4
$11.6K Buy
+12,774
New +$10.9K ﹤0.01% 9169
2024
Q3
Sell
-93,354
Closed -$84.1K 9878
2024
Q2
$84.1K Sell
93,354
-228,976
-71% -$171K ﹤0.01% 8797
2024
Q1
$380K Buy
322,330
+100,527
+45% +$111K ﹤0.01% 7162
2023
Q4
$202K Buy
221,803
+207,912
+1,497% +$154K ﹤0.01% 8201
2023
Q3
$11.6K Sell
13,891
-317,843
-96% -$366K ﹤0.01% 8370
2023
Q2
$398K Sell
331,734
-959,410
-74% -$1.19M ﹤0.01% 6671
2023
Q1
$1.63M Buy
1,291,144
+1,196,672
+1,267% +$2.29M ﹤0.01% 4176
2022
Q4
$205K Sell
94,472
-50,419
-35% -$415K ﹤0.01% 7640
2022
Q3
$1.74M Buy
144,891
+49,194
+51% +$611K ﹤0.01% 4438
2022
Q2
$801K Buy
95,697
+64,006
+202% +$496K ﹤0.01% 5894
2022
Q1
$275K Buy
31,691
+3,726
+13% +$35.9K ﹤0.01% 8535
2021
Q4
$317K Sell
27,965
-20,036
-42% -$238K ﹤0.01% 8064
2021
Q3
$603K Buy
48,001
+27,784
+137% +$256K ﹤0.01% 6917
2021
Q2
$164K Buy
+20,217
New +$175K ﹤0.01% 8974
2021
Q1
Sell
-32,485
Closed -$314K 9284
2020
Q4
$314K Sell
32,485
-6,005
-16% -$59.1K ﹤0.01% 6336
2020
Q3
$477K Buy
+38,490
New +$510K ﹤0.01% 5223

Other funds holding GOSS

Jane Street's GOSS Position: Q1 2026 in Review

Jane Street sold out of Gossamer Bio (GOSS) in Q1 2026, closing a stake of 155,591 shares — an estimated $245K sold.

Jane Street first reported a position in GOSS in Q3 2020 and held it in 19 quarters. The position peaked at $1.85M in Q3 2025. 185 funds tracked by Wall St. Rank hold GOSS as of Q1 2026.

  • Jane Street reported no remaining Gossamer Bio position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 155,591 Gossamer Bio shares in Q1 2026, an estimated $245K.
  • Jane Street first reported a position in Gossamer Bio in Q3 2020 and held it in 19 quarters.
  • Jane Street's Gossamer Bio position peaked at $1.85M in Q3 2025.
  • 185 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.